WebJanssen CarePath for Patients and Caregivers WebMar 22, 2024 · Darzalex is a medicine used to treat adults with multiple myeloma (a cancer of the bone marrow) and light chain (AL) amyloidosis (a blood disease in which deposits of abnormal proteins, called amyloids, accumulate and cause damage in tissues and organs). Multiple myeloma In patients with newly diagnosed multiple myeloma, it is used:
Janssen CarePath for Patients and Caregivers
WebDarzalex Faspro should be administered by a healthcare provider. Multiple Myeloma The recommended dose of Darzakex Faspro is 1,800 mg/30,000 units (1,800 mg … WebNov 15, 2024 · Administer dexamethasone 20 mg (or equivalent) orally or intravenously prior to every DARZALEX FASPRO administration. When dexamethasone is the … arslan zaidi md pain management
HIGHLIGHTS OF PRESCRIBING INFORMATION
WebJul 21, 2024 · Effective with date of service May 6, 2024, the Medicaid and NC Health Choice programs cover daratumumab and hyaluronidase-fihj injection, for subcutaneous use (Darzalex Faspro™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J9999 - Not otherwise classified, antineoplastic drugs. WebVI. Billing Code/Availability Information HCPCS code: • J9999 - Not otherwise classified, antineoplastic drugs • C9399 - Unclassified drugs or biologicals (hospital outpatient use) NDC(s): • Darzalex Faspro 1,800 mg of daratumumab and 30,000 units of hyaluronidase per 15 mL single-dose vial: 57894-0503-xx VII. References 1. Web• Administer medications before and after administration of DARZALEX FASPRO to minimize administration-related reactions [see Dosage and Administration (2.5)]. • … ars latein konjugation